Mutua de Terrassa -ko ikertzaileekin lankidetzan egindako argitalpenak (25)

2023

  1. Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failure

    Frontiers in Aging Neuroscience, Vol. 15

2022

  1. Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again

    Parkinsonism and Related Disorders, Vol. 99, pp. 33-41

2021

  1. Exome-wide rare variant analysis in familial essential tremor

    Parkinsonism and Related Disorders, Vol. 82, pp. 109-116

  2. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  3. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study

    Parkinsonism and Related Disorders, Vol. 65, pp. 3-12

  2. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

    npj Parkinson's Disease, Vol. 5, Núm. 1

  3. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

    npj Parkinson's Disease, Vol. 5, Núm. 1

  4. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

  5. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

    Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863

2018

  1. Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy

    Parkinsonism and Related Disorders, Vol. 46, pp. 16-23

2016

  1. MAPT association with REM sleep behavior disorder

    Neurology: Genetics, Vol. 3, Núm. 1

  2. One-Year reference norms of cognitive change in Spanish old adults: Data from the NEURONORMA Sample

    Archives of Clinical Neuropsychology, Vol. 31, Núm. 4, pp. 378-388

2014

  1. Diagnostic validity of the alzheimer's disease functional assessment and change scale in mild cognitive impairment and mild to moderate alzheimer's disease

    Dementia and Geriatric Cognitive Disorders, Vol. 37, Núm. 5-6, pp. 366-375

  2. Spanish multicenter normative studies (NEURONORMA project): Normative data and equivalence of four BNT short-form versions

    Archives of Clinical Neuropsychology, Vol. 29, Núm. 1, pp. 60-74

2012

  1. Using artificial neural networks in clinical neuropsychology: High performance in mild cognitive impairment and Alzheimer's disease

    Journal of Clinical and Experimental Neuropsychology, Vol. 34, Núm. 2, pp. 195-208

2011

  1. Spanish multicenter normative studies (neuronorma project): Norms for the abbreviated barcelona test

    Archives of Clinical Neuropsychology, Vol. 26, Núm. 2, pp. 144-157

2009

  1. Spanish multicenter normative studies (NEURONORMA project): Methods and sample characteristics

    Archives of Clinical Neuropsychology, Vol. 24, Núm. 4, pp. 307-319

  2. Spanish multicenter normative studies (NEURONORMA project): Norms for boston naming test and token test

    Archives of Clinical Neuropsychology, Vol. 24, Núm. 4, pp. 343-354